These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5441133)

  • 1. The metabolism of pyrovalerone hydrochloride.
    Michaelis W; Russel JH; Schindler O
    J Med Chem; 1970 May; 13(3):497-503. PubMed ID: 5441133
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of polysorbate 80 on the solubility and in vivo availability of 2-butyl-3-benzofuranyl 4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl ketone hydrochloride (SK&F 33134-A).
    Ravin LJ; Shami EG; Intoccia A; Rattie E; Joseph G
    J Pharm Sci; 1969 Oct; 58(10):1242-5. PubMed ID: 5349112
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the disposition of the anticonvulsant clonazepam in the organisms of rat, dog, and man].
    Eschenhof E
    Arzneimittelforschung; 1973 Mar; 23(3):390-400. PubMed ID: 4740124
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolism of nitrilotriacetic acid (NTA).
    Michael WR; Wakim JM
    Toxicol Appl Pharmacol; 1971 Feb; 18(2):407-16. PubMed ID: 4998754
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolism of a pharmacologically active pyrrolidine derivative (prolintane) by lactam formation.
    Hucker HB; Stauffer SC; Rhodes RE
    Experientia; 1972 Apr; 28(4):430-1. PubMed ID: 5036566
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacokinetic studies following oral administration of 3,7-dimethyl-1-(5-oxo-hexyl)xanthine- 14 C (BL 191- 14 C) in rats, dogs and man].
    Christ O; Gleixner K; Kellner HM; Müller R; Rupp W
    Arzneimittelforschung; 1972 Nov; 22(11):1933-7. PubMed ID: 4679068
    [No Abstract]   [Full Text] [Related]  

  • 7. [Radiotracer of the distribution of a new psychotropic agent in mice: L-2-pyrrolidone-5-carboxylate of dimethylaminoethanol. I. Comparison with L-glutamic and L-2 pyrrolidone-5-carboxylic acids].
    Chanal JL; Marignan R; Cousse H; Baldet M
    Therapie; 1972; 27(1):35-46. PubMed ID: 5017555
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolic fate of the short-acting peripheral neuromuscular blocking agent stercuronium in the rat, as related to its action.
    Hespe W; Wieriks J
    Biochem Pharmacol; 1971 Jun; 20(6):1213-24. PubMed ID: 5118118
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies with 14C-labelled noxiptilin. Metabolism and kinetics].
    Duhm B; Maul W; Medenwald H; Patzschke K; Wegner L
    Arzneimittelforschung; 1969 Jun; 19():Suppl 5a:858+. PubMed ID: 5819765
    [No Abstract]   [Full Text] [Related]  

  • 10. [Absorption, distribution and excretion rate in diphenyldioxypyrazolidine drugs -14 C-kebuzon and 14 C- trimetazon- in rats].
    Queisnerová M; Nĕmecek O
    Cesk Farm; 1971 Mar; 20(2):55-9. PubMed ID: 5550003
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changes in the rate of glucose C-14 absorption and incorporation into organs and tissues during hypoxia].
    Smirnov KV; Babkina OI
    Biull Eksp Biol Med; 1970 Dec; 70(12):29-31. PubMed ID: 5503805
    [No Abstract]   [Full Text] [Related]  

  • 12. On the distribution and metabolism of neuroleptic drugs. 3. Pharmacokinetics of trifluperidol.
    Lewi PJ; Heykants JJ; Janssen PA
    Arzneimittelforschung; 1970 Nov; 20(11):1701-5. PubMed ID: 5536974
    [No Abstract]   [Full Text] [Related]  

  • 13. Tissue distribution of CT 1341 in the rat; an autoradiographic study.
    Card B; McCulloch RJ; Pratt DA
    Postgrad Med J; 1972 Jun; 48():Suppl 2:34-7. PubMed ID: 5072041
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on the resorption and metabolism of the antidepressant 9,9-dimethyl-10-(3-dimethyl-aminopropyl)-acridan-hydrogen tartrate].
    Schatz F; Jahn U; Adrian RW; Molnar I
    Arzneimittelforschung; 1968 Jul; 18(7):862-71. PubMed ID: 5755833
    [No Abstract]   [Full Text] [Related]  

  • 15. Excretion and distribution of thiazesim-14C with its biotransformation in vivo and in vitro.
    Dreyfuss J; Swoap JR; Chinn C; Hess SM
    J Pharm Sci; 1968 Sep; 57(9):1497-505. PubMed ID: 5677686
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies of C-14-protriptyline man: plasma levels and excretion.
    Charalampous KD; Johnson PC
    J Clin Pharmacol J New Drugs; 1967; 7(2):93-6. PubMed ID: 5230428
    [No Abstract]   [Full Text] [Related]  

  • 17. Application of clearance concepts to some literature data on drug metabolism in the isolated perfused liver preparation and in vivo.
    Rowland M
    Eur J Pharmacol; 1972 Mar; 17(3):352-6. PubMed ID: 5022150
    [No Abstract]   [Full Text] [Related]  

  • 18. Distribution, excretion metabolism and localization of a new anti-inflammatory drug: niflumic acid, labelled with 14C.
    Glasson B; Benakis A; Strolin-Benedetti M
    Biochem Pharmacol; 1969 Mar; 18(3):633-43. PubMed ID: 5772593
    [No Abstract]   [Full Text] [Related]  

  • 19. Medium-chain triglycerides.
    Greenberger NJ; Skillman TG
    N Engl J Med; 1969 May; 280(19):1045-58. PubMed ID: 4888178
    [No Abstract]   [Full Text] [Related]  

  • 20. Distribution and metabolism of chlorphentermine-C14 in rats and mice.
    Dubnick B; Towne CA; Hartigan JM; Phillips GE
    Biochem Pharmacol; 1968 Jul; 17(7):1243-50. PubMed ID: 4873073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.